LumiraDx Limited
LumiraDx Limited (LMDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LMDX · as of Jun 9, 2026
Key Statistics
Explore LumiraDx Limited Data
lmdx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The LMDX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +9275.00% upside from the current price of $0.02.
Competitors & Peers
lmdx competitorsLMDX
DMTKQ
GBNH
NEUP
NSTG
NVTAStock Performance
Full HistoryAbout LumiraDx Limited
LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic ins…
what is lumiradx limited · lmdx stock overview · lumiradx limited company profile · who is lumiradx limited ceo · lmdx NASDAQ · lumiradx limited headquarters · lumiradx limited business segments
About Stock Overview & Key Data
LumiraDx Limited (LMDX) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Mar 19, 2021. As of the latest trading session, LMDX stock price is $0.02, with a market capitalization of $5.1M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for LumiraDx Limited stock is Buy, with an average 12-month price target of $1.50. In fiscal year 2022, LumiraDx Limited reported revenue of $254.5M and net income of -$449.2M. For detailed data — including LumiraDx Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LumiraDx Limited (LMDX) stock price is $0.02. The stock is traded on NASDAQ under the ticker symbol LMDX. The 52-week range is $0.02 – $0.03.